Krämer OH - Search Results

1

Pasteurella multocida toxin- induced osteoclastogenesis requires mTOR activation.

Kloos B, Chakraborty S, Lindner SG, Noack K, Harre U, Schett G, Krämer OH, Kubatzky KF. Kloos B, et al. Among authors: kramer oh. Cell Commun Signal. 2015 Sep 14;13:40. doi: 10.1186/s12964-015-0117-7. Cell Commun Signal. 2015. PMID: 26369790 Free PMC article.

2

Histone deacetylase inhibitors block IFNγ-induced STAT1 phosphorylation.

Ginter T, Bier C, Knauer SK, Sughra K, Hildebrand D, Münz T, Liebe T, Heller R, Henke A, Stauber RH, Reichardt W, Schmid JA, Kubatzky KF, Heinzel T, Krämer OH. Ginter T, et al. Among authors: kramer oh. Cell Signal. 2012 Jul;24(7):1453-60. doi: 10.1016/j.cellsig.2012.02.018. Epub 2012 Mar 7. Cell Signal. 2012. PMID: 22425562

3

Caspase-3 and caspase-6 cleave STAT1 in leukemic cells.

Licht V, Noack K, Schlott B, Förster M, Schlenker Y, Licht A, Krämer OH, Heinzel T. Licht V, et al. Among authors: kramer oh. Oncotarget. 2014 Apr 30;5(8):2305-17. doi: 10.18632/oncotarget.1911. Oncotarget. 2014. PMID: 24810717 Free PMC article.

4

Analyzing the Impact of Pan- and Class-Specific HDACi on Differentiation-Associated Factors.

Noack K, Krämer OH. Noack K, et al. Among authors: kramer oh. Methods Mol Biol. 2017;1510:375-385. doi: 10.1007/978-1-4939-6527-4_28. Methods Mol Biol. 2017. PMID: 27761836

5

Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells.

Noack K, Mahendrarajah N, Hennig D, Schmidt L, Grebien F, Hildebrand D, Christmann M, Kaina B, Sellmer A, Mahboobi S, Kubatzky K, Heinzel T, Krämer OH. Noack K, et al. Among authors: kramer oh. Arch Toxicol. 2017 May;91(5):2191-2208. doi: 10.1007/s00204-016-1878-5. Epub 2016 Nov 2. Arch Toxicol. 2017. PMID: 27807597 Free PMC article.

6

The protein phosphatase-2A subunit PR130 is involved in the formation of cytotoxic protein aggregates in pancreatic ductal adenocarcinoma cells.

Nguyen A, Mustafa AM, Leydecker AK, Halilovic M, Murr J, Butter F, Krämer OH. Nguyen A, et al. Among authors: kramer oh. Cell Commun Signal. 2024 Apr 3;22(1):217. doi: 10.1186/s12964-024-01597-8. Cell Commun Signal. 2024. PMID: 38570831 Free PMC article.

7

Apoptosis induced by temozolomide and nimustine in glioblastoma cells is supported by JNK/c-Jun-mediated induction of the BH3-only protein BIM.

Tomicic MT, Meise R, Aasland D, Berte N, Kitzinger R, Krämer OH, Kaina B, Christmann M. Tomicic MT, et al. Among authors: kramer oh. Oncotarget. 2015 Oct 20;6(32):33755-68. doi: 10.18632/oncotarget.5274. Oncotarget. 2015. PMID: 26418950 Free PMC article.

8

MTOR inhibitor-based combination therapies for pancreatic cancer.

Hassan Z, Schneeweis C, Wirth M, Veltkamp C, Dantes Z, Feuerecker B, Ceyhan GO, Knauer SK, Weichert W, Schmid RM, Stauber R, Arlt A, Krämer OH, Rad R, Reichert M, Saur D, Schneider G. Hassan Z, et al. Among authors: kramer oh. Br J Cancer. 2018 Feb 6;118(3):366-377. doi: 10.1038/bjc.2017.421. Epub 2018 Jan 2. Br J Cancer. 2018. PMID: 29384525 Free PMC article.

9

A phosphorylation-acetylation switch regulates STAT1 signaling.

Krämer OH, Knauer SK, Greiner G, Jandt E, Reichardt S, Gührs KH, Stauber RH, Böhmer FD, Heinzel T. Krämer OH, et al. Genes Dev. 2009 Jan 15;23(2):223-35. doi: 10.1101/gad.479209. Genes Dev. 2009. PMID: 19171783 Free PMC article.

10

HDAC2: a critical factor in health and disease.

Krämer OH. Krämer OH. Trends Pharmacol Sci. 2009 Dec;30(12):647-55. doi: 10.1016/j.tips.2009.09.007. Epub 2009 Nov 4. Trends Pharmacol Sci. 2009. PMID: 19892411 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page